Pricing Log in Create free account

Affimed N.V. (AFMDQ) vs XORTX Therapeutics Inc. (XRTX)

Affimed N.V. and XORTX Therapeutics Inc. are both Biotechnology companies. Affimed N.V. and XORTX Therapeutics Inc. are of similar size ($2.8M and $2.6M). XORTX Therapeutics Inc. has the higher net margin (0.00% vs −7,834.6%) and the higher return on invested capital (−54.3% vs −13,558.8%). Across the 13 metrics below, XORTX Therapeutics Inc. leads on 10 and Affimed N.V. on 3.

Valuation

Metric AFMDQ XRTX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 0.36 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.26 n/m 0.64
EV/Sales (19.16) n/m 9.21
Earnings yield 0.00% (220.16%) (33.15%)
Free cash flow yield 0.00% (263.28%) (25.50%)

Profitability

Metric AFMDQ XRTX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (7,858.63%) 0.00% 0.00%
Net margin (7,834.59%) 0.00% 0.00%
Free cash flow margin (8,603.91%) 0.00% 0.00%
Return on equity (148.64%) (99.24%) (56.36%)
Return on assets (86.68%) (83.78%) (48.04%)
Return on invested capital (13,558.83%) (54.27%) 0.00%

Growth

Metric AFMDQ XRTX Biotechnology median
Revenue growth (TTM) (95.23%) — 6.02%
EPS growth (last fiscal year) (21.75%) 51.30% 30.26%
Revenue growth, 5-year CAGR (20.40%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AFMDQ XRTX Biotechnology median
Debt to equity 0.47 0.00 0.00
Current ratio 1.93 3.59 4.72
Net debt to EBITDA 0.58 0.28 0.96

Dividend

Metric AFMDQ XRTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AFMDQ XRTX Biotechnology median
Market cap 2.76m 2.58m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack